Literature DB >> 10559789

Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin.

M L Rodriguez-Puebla1, M LaCava, M F Bolontrade, J Russell, C J Conti.   

Abstract

The ras proto-oncogene family products are membrane-associated, guanine nucleotide-binding proteins that serve as a molecular switch for signal transduction pathways in a diverse array of organisms. In the mouse skin two-stage carcinogenesis model, a specific point mutation in Ha-ras codon 61 is responsible for the initiation event. Here we investigated whether Ha-ras protein and mRNA expression change during premalignant progression. Also, we assessed the Ha-ras mutated allele after these changes. To those ends, we analysed the Ha-ras expression profiles in normal and hyperplastic skin, papillomas, and squamous cell carcinomas by western blotting, reverse transcription-polymerase chain reaction, and in situ hybridization. Increased levels of Ha-ras expression were observed at specific times during promotion. These changes were followed by an increase in the level of expression of the Ha-ras mutated allele. These results suggest that increased expression of Ha-ras mutated alleles may have an important role during premalignant progression. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559789

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

Review 1.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

2.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

3.  Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.

Authors:  Xian Wang; Christopher Sistrunk; Paula L Miliani de Marval; Yongbaek Kim; Marcelo L Rodriguez-Puebla
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

4.  Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.

Authors:  Marcelo L Rodriguez-Puebla; Paula L Miliani de Marval; Margaret LaCava; David S Moons; Hiroaki Kiyokawa; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  Stem Cell Lineage Infidelity Drives Wound Repair and Cancer.

Authors:  Yejing Ge; Nicholas C Gomez; Rene C Adam; Maria Nikolova; Hanseul Yang; Akanksha Verma; Catherine Pei-Ju Lu; Lisa Polak; Shaopeng Yuan; Olivier Elemento; Elaine Fuchs
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

6.  The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development.

Authors:  Kyung-Soo Chun; Huei-Chen Lao; Carol S Trempus; Manabu Okada; Robert Langenbach
Journal:  Carcinogenesis       Date:  2009-07-08       Impact factor: 4.944

7.  Enhanced malignant tumorigenesis in Cdk4 transgenic mice.

Authors:  Paula L Miliani de Marval; Everardo Macias; Claudio J Conti; Marcelo L Rodriguez-Puebla
Journal:  Oncogene       Date:  2004-03-11       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.